Dean Regier appointed Chair for the new Regulatory Advisory Council at Academy of Translational Medicine
He will provide leadership to establish the Regulatory Advisory Council and the Academy of Translational Medicine as leaders in regulatory affairs in Canada.
Halting COVID-19 in its tracks
UBC researchers are investigating a novel aerosol treatment to stop the virus from replicating.
UBC researchers develop new test to diagnose aggressive childhood brain tumours
The test could help pave the way for personalized treatment options for children suffering from the disease.
Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
UBC researchers have found Axitinib can restore memory and cognitive function in mice.
Study finds new biomarker for a disease caused by bone marrow transplant
The discovery could lead to new ways to diagnose and treat the disease.
New study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies
UBC and BC Cancer researchers have uncovered a weakness in a key enzyme that solid tumour cancer cells rely on to adapt and survive.
Innovative coating for blood vessels reduces rejection of transplanted organs
The breakthrough could one day improve quality of life for transplant patients and improve the lifespan of transplanted organs.
New study to explore potential of magnetic nanoparticles to help treat type 2 diabetes
The two-year project is funded by the Government of Canada’s New Frontiers in Research Fund.
UBC Academy of Translational Medicine director Dr. Poul Sorensen awarded Order of B.C.
Dr. Sorensen is one of 16 British Columbians to receive the Province’s highest form of recognition in 2021.